Pandemic Worsens, But It’s Price Hikes As Usual For Pharma
Vital Drugs Important To COVID-Related Outcomes See Big Bumps.
P4AD Founder David Mitchell’s Testimony before the House Committee on Oversight and Reform
Right now I am on a four-drug combination that carries a list price tag of more than $900,000 per year.
DATA SET: Drug Companies Keep Raising Prices in the Midst of a Pandemic
The first case of COVID-19 in the United States was reported on January 20. According to our analysis, pharmaceutical corporations hiked the prices of 245 drugs between January 20 and June 20.
REPORT: Drug Companies Keep Raising Prices in the Midst of a Pandemic
The first case of COVID-19 in the United States was reported on January 20. According to our analysis, pharmaceutical corporations hiked the prices of 245 drugs between January 20 and June 20.
A Letter to Insulin Manufacturers
We are writing to implore you to take urgent action to improve access to insulin products in light of the current COVID-19 pandemic.